Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Gabather AB (GABA) Stock Price & Analysis

0 Followers

GABA Stock Chart & Stats

kr 0.02kr 0.00(0.00%)
At close: 5:30 PM GMT+1
kr 0.02kr 0.025kr 0.03kr 0.035Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
SEK 0.02 - SEK 0.02
52-Week Range
SEK 0.02 - SEK 0.10
Previous Close
SEK 0.02
Volume
N/A
Average Volume (3M)
2.49M
Market Cap
SEK 11.84M
Enterprise Value
SEK 18.78M
Total Cash (Recent Filing)
SEK 3.69M
Total Debt (Recent Filing)
SEK 0
Price to Earnings (P/E)
―
Beta
0.80
Next Earnings
Nov 27, 2026 (Est.)
EPS Estimate
0
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

The absence of reported debt reduces fixed financial obligations and interest expense, giving Gabather greater flexibility while it advances its drug candidates. This can help preserve strategic options and limit balance-sheet pressure during the company’s ongoing pre-revenue development phase.

Narrowing Losses

Losses have narrowed meaningfully from earlier periods, indicating some improvement in cost control or development economics even though profitability remains distant. If maintained, this trajectory could reduce the rate of capital consumption and extend the company’s ability to fund its pipeline.

Defined CNS Drug Development Focus

A focused strategy around GABA-A receptor biology and CNS disorders gives Gabather a clearly defined scientific direction rather than a broad, unfocused portfolio. Concentrating resources on small-molecule candidates may support specialized development expertise as programs advance through preclinical and clinical stages.

Bears Say

No Revenue Or Commercial Base

Zero revenue means Gabather has not yet demonstrated commercial demand or established a recurring inflow to support operations. Until a candidate reaches commercialization or another source of operating income emerges, business value remains dependent on successful development milestones and external funding.

Persistent Cash Burn

Consistently negative operating and free cash flow show that Gabather is consuming substantial cash without revenue inflows. Continued development therefore requires additional financing or other capital support, creating an ongoing constraint on execution and increasing exposure to funding availability.

Volatile Capital Base

Historically negative equity and materially fluctuating assets indicate capital erosion and an unstable balance-sheet base. Although TTM equity is positive, its modest scale relative to ongoing losses leaves limited financial resilience and reinforces the company’s dependence on future funding events.

GABA FAQ

What was Gabather AB’s price range in the past 12 months?
Gabather AB lowest stock price was kr 0.02 and its highest was kr 0.10 in the past 12 months.
What is Gabather AB’s market cap?
Gabather AB’s market cap is kr 11.84M.
When is Gabather AB’s upcoming earnings report date?
Gabather AB’s next earnings report is estimated for Nov 27, 2026 (not yet confirmed), which is in 21 days.
How were Gabather AB’s earnings last quarter?
Gabather AB released its earnings results on Aug 31, 2026. The company reported kr 0 earnings per share for the quarter.
Is Gabather AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Gabather AB pay dividends?
Gabather AB does not currently pay dividends.
What is Gabather AB’s EPS estimate?
Gabather AB’s EPS estimate is 0.00.
How many shares outstanding does Gabather AB have?
Gabather AB has 610,491,300 shares outstanding.
What happened to Gabather AB’s price movement after its last earnings report?
Gabather AB reported an EPS of kr 0 in its last earnings report. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Gabather AB?
Currently, no hedge funds are holding shares in SE:GABA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology